The Rakon director and former boss has hit out at the Shareholders’ Association’s attempt to limit the influence of the company’s large shareholders.
Net loss deepened to $7.2 million in year to June, amid contract loss and darker economic clouds.
But the company says the result reflects ongoing investment into the business.
NZX-listed software-as-a-service business implements cost-cutting measures as losses mount.
The wellness retailer says outlook remains "challenging" following tough year.
Full-year profit rises to $95.9 million, while net interest margin fell to 3.97%.
Five years after listing across the Tasman as Keytone Enterprises, trading in its shares is suspended with the appointment of receivers.
CEO Grant Webster exceptionally pleased with result but warns markets like North America are heading into softer territory.
The listed health company does not expect a material effect on 2024 earnings guidance.
The NZX-listed publican is set to delist later this year, if shareholders approve the sale of its business.